Abstract
Pneumonia remains the leading cause of death from infection in the US, yet fundamentally new conceptual models underlying its pathogenesis have not emerged. We show that humans and mice with bacterial pneumonia have markedly elevated amounts of cardiolipin, a rare, mitochondrial-specific phospholipid, in lung fluid and find that it potently disrupts surfactant function. Intratracheal cardiolipin administration in mice recapitulates the clinical phenotype of pneumonia, including impaired lung mechanics, modulation of cell survival and cytokine networks and lung consolidation. We have identified and characterized the activity of a unique cardiolipin transporter, the P-type ATPase transmembrane lipid pump Atp8b1, a mutant version of which is associated with severe pneumonia in humans and mice. Atp8b1 bound and internalized cardiolipin from extracellular fluid via a basic residue–enriched motif. Administration of a peptide encompassing the cardiolipin binding motif or Atp8b1 gene transfer in mice lessened bacteria-induced lung injury and improved survival. The results unveil a new paradigm whereby Atp8b1 is a cardiolipin importer whose capacity to remove cardiolipin from lung fluid is exceeded during inflammation or when Atp8b1 is defective. This discovery opens the door for new therapeutic strategies directed at modulating the abundance or molecular interactions of cardiolipin in pneumonia.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Agency for Healthcare Research and Quality. Pneumonia most common reason for hospitalization. AHRQ News and Numbers, July 2, 2008. http://www.ahrq.gov/news/nn/nn070208.htm (2008).
Kadioglu, A., Weiser, J.N., Paton, J.C. & Andrew, P.W. The role of Streptococcus pneumoniae virulence factors in host respiratory colonization and disease. Nat. Rev. Microbiol. 6, 288–301 (2008).
Rooney, S.A., Young, S.L. & Mendelson, C.R. Molecular and cellular processing of lung surfactant. FASEB J. 8, 957–967 (1994).
Liau, D.F., Barrett, C.R., Bell, A.L., Cernansky, G. & Ryan, S.F. Diphosphatidylglycerol in experimental acute alveolar injury in the dog. J. Lipid Res. 25, 678–683 (1984).
Ksenzenko, S.M. et al. Effect of triiodothyronine augmentation on rat lung surfactant phospholipids during sepsis. J. Appl. Physiol. 82, 2020–2027 (1997).
Koppelman, C.M., Den Blaauwen, T., Duursma, M.C., Heeren, R.M. & Nanninga, N. Escherichia coli minicell membranes are enriched in cardiolipin. J. Bacteriol. 183, 6144–6147 (2001).
Whitington, P.F., Freese, D.K., Alonso, E.M., Schwarzenberg, S.J. & Sharp, H.L. Clinical and biochemical findings in progressive familial intrahepatic cholestasis. J. Pediatr. Gastroenterol. Nutr. 18, 134–141 (1994).
Bull, L.N. et al. A gene encoding a P-type ATPase mutated in two forms of hereditary cholestasis. Nat. Genet. 18, 219–224 (1998).
Pawlikowska, L. et al. Differences in presentation and progression between severe FIC1 and BSEP deficiencies. J. Hepatol. 53, 170–180 (2010).
Mizgerd, J.P. Acute lower respiratory tract infection. N. Engl. J. Med. 358, 716–727 (2008).
Dullforce, P., Sutton, D.C. & Heath, A.W. Enhancement of T cell–independent immune responses in vivo by CD40 antibodies. Nat. Med. 4, 88–91 (1998).
Grossmann, G. et al. Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. J. Appl. Physiol. 86, 633–640 (1999).
Paulusma, C.C. et al. Atp8b1 deficiency in mice reduces resistance of the canalicular membrane to hydrophobic bile salts and impairs bile salt transport. Hepatology 44, 195–204 (2006).
Pawlikowska, L. et al. A mouse genetic model for familial cholestasis caused by ATP8B1 mutations reveals perturbed bile salt homeostasis but no impairment in bile secretion. Hum. Mol. Genet. 13, 881–892 (2004).
Borron, P. et al. Surfactant-associated protein A inhibits LPS-induced cytokine and nitric oxide production in vivo. Am. J. Physiol. Lung Cell. Mol. Physiol. 278, L840–L847 (2000).
Yamazoe, M. et al. Pulmonary surfactant protein D inhibits lipopolysaccharide (LPS)-induced inflammatory cell responses by altering LPS binding to its receptors. J. Biol. Chem. 283, 35878–35888 (2008).
Kennedy, J.I. Jr. High alveolar surface tension pulmonary edema—relationship to adult respiratory distress syndrome. J. Thorac. Cardiovasc. Surg. 100, 145–146 (1990).
Albert, R.K., Lakshminarayan, S., Hildebrandt, J., Kirk, W. & Butler, J. Increased surface tension favors pulmonary edema formation in anesthetized dogs' lungs. J. Clin. Invest. 63, 1015–1018 (1979).
Sutrina, S.L. & Scocca, J.J. Phospholipids of Haemophilus influenzae Rd during exponential growth and following the development of competence for genetic transformation. J. Gen. Microbiol. 92, 410–412 (1976).
Kagan, V.E. et al. Cytochrome c acts as a cardiolipin oxygenase required for release of proapoptotic factors. Nat. Chem. Biol. 1, 223–232 (2005).
Sorice, M. et al. Cardiolipin on the surface of apoptotic cells as a possible trigger for antiphospholipids antibodies. Clin. Exp. Immunol. 122, 277–284 (2000).
Wang, Z. & Notter, R.H. Additivity of protein and nonprotein inhibitors of lung surfactant activity. Am. J. Respir. Crit. Care Med. 158, 28–35 (1998).
Ritov, V.B., Menshikova, E.V. & Kelley, D.E. Analysis of cardiolipin in human muscle biopsy. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 831, 63–71 (2006).
Benarafa, C., Priebe, G.P. & Remold-O'Donnell, E. The neutrophil serine protease inhibitor serpinb1 preserves lung defense functions in Pseudomonas aeruginosa infection. J. Exp. Med. 204, 1901–1909 (2007).
McCormack, F.X., King, T.E. Jr., Voelker, D.R., Robinson, P.C. & Mason, R.J. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A. Am. Rev. Respir. Dis. 144, 160–166 (1991).
Hughes, D.A. & Haslam, P.L. Changes in phosphatidylglycerol in bronchoalveolar lavage fluids from patients with cryptogenic fibrosing alveolitis. Chest 95, 82–89 (1989).
Jirsa, M. et al. Indel in the FIC1/ATP8B1 gene—a novel rare type of mutation associated with benign recurrent intrahepatic cholestasis. Hepatol. Res. 30, 1–3 (2004).
van Mil, S.W., Klomp, L.W., Bull, L.N. & Houwen, R.H. FIC1 disease: a spectrum of intrahepatic cholestatic disorders. Semin. Liver Dis. 21, 535–544 (2001).
Frick, A.G. et al. Haemophilus influenzae stimulates ICAM-1 expression on respiratory epithelial cells. J. Immunol. 164, 4185–4196 (2000).
Ujhazy, P. et al. Familial intrahepatic cholestasis 1: studies of localization and function. Hepatology 34, 768–775 (2001).
Frankenberg, T. et al. The membrane protein ATPase class I type 8B member 1 signals through protein kinase C ζ to activate the farnesoid X receptor. Hepatology 48, 1896–1905 (2008).
McCoy, D.M., Fisher, K., Ryan, A.J. & Mallampalli, R.K. Transcriptional regulation of lung cytidylyltransferase in developing transgenic mice. Am. J. Respir. Cell Mol. Biol. 35, 394–402 (2006).
Chen, B.B. & Mallampalli, R.K. Calmodulin binds and stabilizes the regulatory enzyme, CTP: phosphocholine cytidylyltransferase. J. Biol. Chem. 282, 33494–33506 (2007).
Zhou, J. et al. Adenoviral gene transfer of a mutant surfactant enzyme ameliorates Pseudomonas-induced lung injury. Gene Ther. 13, 974–985 (2006).
Bligh, E.G. & Dyer, W.J. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37, 911–917 (1959).
Folch, J., Lees, M. & Sloane Stanley, G.H. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497–509 (1957).
Kaewsuya, P., Danielson, N.D. & Ekhterae, D. Fluorescent determination of cardiolipin using 10-N-nonyl acridine orange. Anal. Bioanal. Chem. 387, 2775–2782 (2007).
Mallampalli, R.K., Ryan, A.J., Salome, R.G. & Jackowski, S. Tumor necrosis factor-alpha inhibits expression of CTP:phosphocholine cytidylyltransferase. J. Biol. Chem. 275, 9699–9708 (2000).
Acknowledgements
We thank M.E. Anderson, M.J. Welsh, J. Zabner and M. Gladwin for critical review of the manuscript and helpful suggestions. The Atp8b1G308V/G308V 129S1/SvlmJ mutant mice14 were a generous gift from L. Bull (University of California–San Francisco). Nontypable H. influenza strain 12 bacteria were kindly provided by D. Look (University of Iowa)29. Antibodies to ATP8b1 were generous gifts from D. Ortiz (Tufts University)30 and M. Ananthanarayanan (Mount Sinai School of Medicine)31. This material is based upon work supported, in part, by the US Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Biomedical Laboratory Research and Development. This work was supported by a Merit Review Award from the US Department of Veterans Affairs and US National Institutes of Health R01 grants HL068135, HL080229, HL081784, HL096376, HL097376 and HL098174 (to R.K.M.), HL70755, HL094488 and NIOSH OH008282 (to V.E.K.) and K23 HL075402 and U01 HL102288 (to L.D.). The contents do not represent the views of the Department of Veterans Affairs or the US government.
Author information
Authors and Affiliations
Contributions
N.B.R. designed and executed cardiolipin-ATP8b1 binding, in vitro imaging and immunological studies and wrote the manuscript. L.D. edited the manuscript and conducted the human studies. B.B.C. performed in vitro (cardiolipin uptake, biochemical and molecular) experiments and all mouse studies. B.J.M. and M.D. contributed to human studies and statistical analyses. A.K.W., T.A.C., M.A., P.L.B., F.C.H. and S.N.M. assisted with in vitro studies. A.J.R. and C.P.O. assisted with mouse studies. D.M.M., E.C.H.-R. and C.A.E. conducted cardiolipin analysis. L.G. conducted surfactant studies. J.C.S. and G.M. designed and conducted in vivo imaging. V.E.K. designed and executed mass spectrometry of cardiolipin, with assistance from Y.Y.T., and provided editorial suggestions. R.K.M. revised the manuscript and directed the study.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Supplementary information
Supplementary Text and Figures
Supplementary Table 1, Supplementary Figures 1–13 and Supplementary Methods (PDF 724 kb)
Rights and permissions
About this article
Cite this article
Ray, N., Durairaj, L., Chen, B. et al. Dynamic regulation of cardiolipin by the lipid pump Atp8b1 determines the severity of lung injury in experimental pneumonia. Nat Med 16, 1120–1127 (2010). https://doi.org/10.1038/nm.2213
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.2213
This article is cited by
-
Lipid flippases as key players in plant adaptation to their environment
Nature Plants (2021)
-
Short exposure to hyperoxia causes cultured lung epithelial cell mitochondrial dysregulation and alveolar simplification in mice
Pediatric Research (2021)
-
Alveolar lipids in pulmonary disease. A review
Lipids in Health and Disease (2020)
-
Graphene-based sensing of oxygen transport through pulmonary membranes
Nature Communications (2020)
-
Mitochondrial biology in airway pathogenesis and the role of NRF2
Archives of Pharmacal Research (2020)